Ortho Clinical Diagnostics Recognized as One of The Economic Times Best Asian Healthcare Brands 2017

Ortho Clinical Diagnostics Recognized as One of The Economic Times Best Asian Healthcare Brands 2017

Dec 20, 2017
U.S.-headquartered Ortho is the only diagnostics company to be recognized by Asia's largest daily business publication

RARITAN, N.J., Dec. 20, 2017 -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has been recognized as one of The Economic Times Best Asian Healthcare Brands for 2017. The Best Asian Healthcare Brands recognize companies operating in Asia that have impacted the community positively, based on extensive research of top brands in various segments of health care to identify the most trustworthy and dependable companies across the industry.

The U.S.-headquartered Ortho was the only diagnostics company to be recognized by The Economic Times. It was chosen in the Medical Devices & Instruments segment category, culled from a list of 47 finalists across all health care categories across Asia.

"This recognition by The Economic Times is a testament to our commitment to our customers. Around the world, our customers rely on us as strategic partners and depend upon our expertise to stay ahead of the changing health care environment," said Alex Socarrás, Ortho's chief commercial officer. "Being named as one of the Best Asian Healthcare Brands confirms our Asian teams' outstanding effectiveness in meeting our customers' needs.  We're honored to receive this distinction and proud of our people."

The Economic Times Best Asian Healthcare Brands was instituted in 2016 to facilitate and acknowledge the leading companies in the Asian health care industry.  It recognizes the brands that have constantly been able to innovate, adapt and leverage the ever-changing marketplace in terms of product offerings, pricing, solutions, business model, packaging, delivery and more.

"Ortho has long been a leader in diagnostics in Asia," said Anand Pande, head of Ortho's Asia-Pacific region. "Our differentiated offerings bring automation and our unique waterless, dry slide technology to clinical laboratories in Asia and around the world, and it's gratifying to see such a prestigious publication recognize the value we bring to our customers." 

More than 150 brands in each segment had been considered as part of the study used to identify the best Asian brands. More than 10,000 patients, consumers, health care professionals and hospital stakeholders across 12 countries in Asia participated in the survey.

Published by the Times Group, The Economic Times is Asia's largest business daily and is among the world's top three English-language business dailies in the world. 

With this, Ortho has once again been honored for its industry leadership. Over the last two years, Ortho has been broadly recognized for customer service, innovation, quality, safety, sustainability and brand renovation with several awards.  These include The Edison Award™ for Global Product Innovation, 2017, which recognized the ORTHO VISION® Analyzer, a fully automated system that tests blood for compatibility with patients receiving blood transfusion. The ORTHO VISION Analyzer also received two Global Business Excellence Awards. Ortho has also been honored with two International Stevie Awards – a 2017 award for Sales and Customer Service and a 2016 award for Re-Branding and Brand Renovation in support of Ortho's brand work and articulating its story as an independent company.  The Ortho Care™ service and support program has been the highest-ranked original equipment manufacturer by ServiceTrak™ for overall service performance in the chemistry and immunoassay market segments for two years running (2016-17), and Ortho was honored with an Innovation Award by members of Premier, Inc., a health care improvement company that unites an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers around the goal of transforming health care.

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2017

Press Contact: 
Jane Ward
Ortho Clinical Diagnostics 

© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.